SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001193125-18-336600
Filing Date
2018-11-28
Accepted
2018-11-28 16:22:05
Documents
1
Period of Report
2018-11-28
Effectiveness Date
2018-11-28

Document Format Files

Seq Description Document Type Size
1 DEF 14C d648624ddef14c.htm DEF 14C 432528
  Complete submission text file 0001193125-18-336600.txt   433578
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-38137 | Film No.: 181205877
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1